Understanding how a specific enzyme in microbes affects human health
Toward understanding the chemistry and biology of microbial DXP synthase
This study is looking at an important enzyme in gut bacteria that could help us understand how to fight infections better, and it’s for anyone interested in new ways to tackle harmful germs in our bodies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10876501 on NIH RePORTER |
What this research studies
This research investigates the enzyme 1-deoxy-D-xylulose 5-phosphate synthase (DXPS), which is crucial for the production of important metabolites in gut bacteria and pathogens. By studying how DXPS functions and responds to its environment, the research aims to uncover its role in the human microbiome and its potential as a target for new antimicrobial therapies. The approach includes examining the enzyme's unique mechanisms and developing strategies to inhibit its activity, which could lead to advancements in treating infections caused by harmful microbes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with infections caused by pathogenic bacteria or those interested in the effects of gut microbiota on health.
Not a fit: Patients who do not have infections or conditions related to microbial imbalances may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for infections by targeting specific microbial enzymes, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in targeting microbial enzymes for therapeutic purposes, indicating potential success for this approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Freel Meyers, Caren L. — Johns Hopkins University
- Study coordinator: Freel Meyers, Caren L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.